Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HMGB3P2 (High mobility group box 3 pseudogene 2, dJ550H1.1) is a human pseudogene related to the high mobility group box 3 (HMGB3) gene family. Pseudogenes are segments of DNA that resemble functional genes but typically lack protein-coding ability due to mutations, deletions, or other genomic alterations. HMGB3P2 shares sequence similarity with HMGB3 but does not produce a functional protein product [1][4][7]. Pseudogenes like HMGB3P2 can sometimes exert biological effects by influencing regulatory networks, such as acting as competitive endogenous RNAs or miRNA decoys, but no specific biological or disease relevance has been attributed to HMGB3P2 itself[2][6]. HMGB3P2 is not considered a conventional therapeutic target and does not interact with approved drugs. It is primarily annotated as a genomic element in reference databases and research literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 3 pseudogene 2 (HMGB3P2).